NCT05820165

Brief Summary

Cerebral venous outflow disturbance can lead to cerebral hemodynamic disturbances, altered cerebrospinal fluid dynamics, cerebral venous blood stasis, increased cerebral venous pressure and decreased cerebral perfusion, cerebral white matter sparing-like changes, and widening of retinal vessel diameter. These changes are associated with numerous neurological signs and symptoms. Therefore, understanding the brain structural and functional changes in patients with cerebral venous outflow disturbance is essential to provide specific imaging evaluation indicators and new diagnosis and treatment methods for patients with cerebral venous return disorders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 14, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

10 months

First QC Date

April 14, 2023

Last Update Submit

April 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • voxel-based morphometry

    Voxel-based morphometry (VBM) is used to obtain the relative gray matter volume (GMV) and WM volume (WMV)

    at admission

Secondary Outcomes (1)

  • The amplitude of low-frequency fluctuations (ALFF)

    at admission

Other Outcomes (10)

  • Regional homogeneity (ReHo)

    at admission

  • Voxel-wise functional connectivity (FC)

    at admission

  • Tract-based spatial statistics (TBSS) analysis

    at admission

  • +7 more other outcomes

Study Arms (3)

CVOD-WS

Cerebral Venous Outflow Disturbance with symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline

Radiation: high-resolution 3D-T1Radiation: diffusion tensor imaging (DTI)Radiation: resting-state functional magnetic resonance imaging (rs-fMRI)Radiation: arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)Radiation: susceptibility-weighted images (SWIs)

CVOD-WOS

Cerebral Venous Outflow Disturbance without symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline

Radiation: high-resolution 3D-T1Radiation: diffusion tensor imaging (DTI)Radiation: resting-state functional magnetic resonance imaging (rs-fMRI)Radiation: arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)Radiation: susceptibility-weighted images (SWIs)

HC

Healthy control

Radiation: high-resolution 3D-T1Radiation: diffusion tensor imaging (DTI)Radiation: resting-state functional magnetic resonance imaging (rs-fMRI)Radiation: arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)Radiation: susceptibility-weighted images (SWIs)

Interventions

Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images

CVOD-WOSCVOD-WSHC

Subjects undergo a DTI imaging to obtain images of white matter lesions

CVOD-WOSCVOD-WSHC

Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity

CVOD-WOSCVOD-WSHC

Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions

CVOD-WOSCVOD-WSHC

Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network

CVOD-WOSCVOD-WSHC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with cerebral venous outflow disturbance( moderate to severe stenosis in cerebral venous sinus or intracranial jugular veins )

You may qualify if:

  • Cerebral venous outflow disturbance( moderate to severe stenosis in cerebral venous sinus or intracranial jugular veins ) is confirmed by two of magnetic resonance venography (MRV), computed tomography venography (CTV) or digital subtraction angiography (DSA)
  • Accompanying symptoms such as tinnitus cerebri, cognitive decline, anxiety depression, sleep disorders, etc. for more than 6 months

You may not qualify if:

  • ear primary disease medicine related intracranial hypertension; Systemic disease of abnormal metabolism or inflammation; moderate to severe stenosis in intracranial, carotid or vertebral arteries; intracranial lesions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuanwu hospital;Capital Medical University

Beijin, XI Cheng District, 100053, China

RECRUITING

Related Publications (1)

  • Luan Y, Wang C, Jiao Y, Tang T, Zhang J, Teng GJ. Prefrontal-Temporal Pathway Mediates the Cross-Modal and Cognitive Reorganization in Sensorineural Hearing Loss With or Without Tinnitus: A Multimodal MRI Study. Front Neurosci. 2019 Mar 12;13:222. doi: 10.3389/fnins.2019.00222. eCollection 2019.

    PMID: 30930739BACKGROUND

Biospecimen

Retention: NONE RETAINED

Blood samples from enrolled participants are drawn by nurse using containing coagulant tubes.

MeSH Terms

Interventions

Diffusion Tensor Imaging

Intervention Hierarchy (Ancestors)

NeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiffusion Magnetic Resonance ImagingMagnetic Resonance ImagingTomographyDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • Xunming Ji, MD.PhD

    Xuanwu Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 14, 2023

First Posted

April 19, 2023

Study Start

March 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

April 19, 2023

Record last verified: 2023-04

Locations